Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07611786 · ClinicalTrials.gov registry record
Development of Healthcare Transition for Patients With Congenital Adrenal Hyperplasia
A clinical trial, sponsored by University of Alabama at Birmingham.
- Not yet
- Registry status
- 40
- Enrollment target
NCT07611786: Clinical Trial study, sponsored by University of Alabama at Birmingham.
NCT07611786 is a clinical trial that has not yet begun recruiting, run by University of Alabama at Birmingham. The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07611786 has not yet begun recruiting, sponsored by University of Alabama at Birmingham.
- NOT YET RECRUITING
- Registry status
- 40 participants
- Enrollment target
Study Summary
The purpose of this study is to implement and evaluate the feasibility and acceptability of a structured healthcare transition program for adolescents and young adults with congenital adrenal hyperplasia (CAH). The study will also examine preliminary effects of the program on transition readiness, disease-specific self-management knowledge, emergency preparedness, continuity of endocrine care, and health-related quality of life as participants transition from pediatric to adult healthcare services.
Primary Outcome
Brief survey of CAH knowledge with Congenital adrenal hyperplasia knowledge questionnaire looking at the treatment of the condition and the mechanism of congenital adrenal hyperplasia. Minimum score 0; Maximum score 44; with 0 indicating lack of knowledge of CAH
Interventions
- OTHER exposure to healthcare transition protocol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2026-07 |
| Est. Completion | 2029-07 |
What is known before NCT07611786 opens enrollment
NCT07611786 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which exposure to healthcare transition protocol is the first listed.
NCT07611786 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07611786 about?
NCT07611786 is a clinical study titled "Development of Healthcare Transition for Patients With Congenital Adrenal Hyperplasia". The purpose of this study is to implement and evaluate the feasibility and acceptability of a structured healthcare transition program for adolescents and young adults with congenital adrenal hyperplasia (CAH). The study will also examine preliminary effects of the program on transition readiness, d...
What is the current status of trial NCT07611786?
This trial is currently not yet recruiting. The enrollment target is 40 participants. The study started on 2026-07. Estimated completion is 2029-07.
What interventions are being tested in trial NCT07611786?
The interventions under investigation include: exposure to healthcare transition protocol (OTHER).
Who is sponsoring clinical trial NCT07611786?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia